An affordable anti-SARS-COV-2 spike protein ELISA test for early detection of IgG seroconversion suited for large-scale surveillance studies in low-income countries
View ORCID ProfileRenata G. F. Alvim, Tulio M. Lima, View ORCID ProfileDanielle A. S. Rodrigues, Federico F. Marsili, Vicente B.T. Bozza, View ORCID ProfileLuiza M. Higa, Fabio L. Monteiro, View ORCID ProfileIsabela C. Leitão, View ORCID ProfileRenato S. Carvalho, View ORCID ProfileRafael M. Galliez, View ORCID ProfileTerezinha M. P. P. Castineiras, View ORCID ProfileAlberto Nobrega, View ORCID ProfileLeonardo H. Travassos, View ORCID ProfileOrlando C. Ferreira Jr., View ORCID ProfileAmilcar Tanuri, View ORCID ProfileAndré M. Vale, View ORCID ProfileLeda R. Castilho
doi: https://doi.org/10.1101/2020.07.13.20152884
Renata G. F. Alvim
1COPPE, Chemical Engineering Program, Cell Culture Engineering Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
Tulio M. Lima
1COPPE, Chemical Engineering Program, Cell Culture Engineering Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
2School of Chemistry, EPQB Program, Federal University of Rio de Janeiro - UFRJ, Brazil
Danielle A. S. Rodrigues
3Institute of Microbiology, Immunology Dept., Federal University of Rio de Janeiro - UFRJ, Brazil
Federico F. Marsili
1COPPE, Chemical Engineering Program, Cell Culture Engineering Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
4Institute of Chemistry, Biochemistry Program, Federal University of Rio de Janeiro - UFRJ, Brazil
Vicente B.T. Bozza
5Institute of Biophysics Carlos Chagas Filho, Program in Immunobiology, Federal University of Rio de Janeiro - UFRJ, Brazil
Luiza M. Higa
6Biology Institute, Genetics Dept., Molecular Virology Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
Fabio L. Monteiro
6Biology Institute, Genetics Dept., Molecular Virology Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
Isabela C. Leitão
5Institute of Biophysics Carlos Chagas Filho, Program in Immunobiology, Federal University of Rio de Janeiro - UFRJ, Brazil
Renato S. Carvalho
7School of Pharmacy, Pharmaceutical Biotechnology Dept., Federal University of Rio de Janeiro - UFRJ, Brazil
Rafael M. Galliez
8Medical School, Infectious and Parasitic Disease Dept., Federal University of Rio de Janeiro - UFRJ, Brazil
Terezinha M. P. P. Castineiras
8Medical School, Infectious and Parasitic Disease Dept., Federal University of Rio de Janeiro - UFRJ, Brazil
Alberto Nobrega
3Institute of Microbiology, Immunology Dept., Federal University of Rio de Janeiro - UFRJ, Brazil
Leonardo H. Travassos
5Institute of Biophysics Carlos Chagas Filho, Program in Immunobiology, Federal University of Rio de Janeiro - UFRJ, Brazil
Orlando C. Ferreira Jr.
6Biology Institute, Genetics Dept., Molecular Virology Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
Amilcar Tanuri
6Biology Institute, Genetics Dept., Molecular Virology Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
André M. Vale
5Institute of Biophysics Carlos Chagas Filho, Program in Immunobiology, Federal University of Rio de Janeiro - UFRJ, Brazil
Leda R. Castilho
1COPPE, Chemical Engineering Program, Cell Culture Engineering Lab, Federal University of Rio de Janeiro - UFRJ, Brazil
4Institute of Chemistry, Biochemistry Program, Federal University of Rio de Janeiro - UFRJ, Brazil
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The raw data of all experiments are available upon request.
Posted August 02, 2020.
An affordable anti-SARS-COV-2 spike protein ELISA test for early detection of IgG seroconversion suited for large-scale surveillance studies in low-income countries
Renata G. F. Alvim, Tulio M. Lima, Danielle A. S. Rodrigues, Federico F. Marsili, Vicente B.T. Bozza, Luiza M. Higa, Fabio L. Monteiro, Isabela C. Leitão, Renato S. Carvalho, Rafael M. Galliez, Terezinha M. P. P. Castineiras, Alberto Nobrega, Leonardo H. Travassos, Orlando C. Ferreira Jr., Amilcar Tanuri, André M. Vale, Leda R. Castilho
medRxiv 2020.07.13.20152884; doi: https://doi.org/10.1101/2020.07.13.20152884
An affordable anti-SARS-COV-2 spike protein ELISA test for early detection of IgG seroconversion suited for large-scale surveillance studies in low-income countries
Renata G. F. Alvim, Tulio M. Lima, Danielle A. S. Rodrigues, Federico F. Marsili, Vicente B.T. Bozza, Luiza M. Higa, Fabio L. Monteiro, Isabela C. Leitão, Renato S. Carvalho, Rafael M. Galliez, Terezinha M. P. P. Castineiras, Alberto Nobrega, Leonardo H. Travassos, Orlando C. Ferreira Jr., Amilcar Tanuri, André M. Vale, Leda R. Castilho
medRxiv 2020.07.13.20152884; doi: https://doi.org/10.1101/2020.07.13.20152884
Subject Area
Subject Areas
- Addiction Medicine (337)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2608)
- Dermatology (220)
- Emergency Medicine (392)
- Epidemiology (12150)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4038)
- Geriatric Medicine (381)
- Health Economics (672)
- Health Informatics (2609)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (835)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3811)
- Nursing (208)
- Nutrition (567)
- Oncology (1997)
- Ophthalmology (580)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1103)
- Primary Care Research (443)
- Public and Global Health (6478)
- Radiology and Imaging (1380)
- Respiratory Medicine (867)
- Rheumatology (396)
- Sports Medicine (337)
- Surgery (439)
- Toxicology (52)
- Transplantation (185)
- Urology (165)